Byline: Will Doss
-
Identifying Mechanisms of Methylation in Stem Cells
Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.
-
McGaw Holds Second Annual Health Equity Week
The McGaw Medical Center of Northwestern University hosted its second annual Health Equity Week, a series of panel discussions highlighting the roots of healthcare disparities and how clinicians and scientists are working to find solutions.
-
Transitional Care Practice Reduces Costs
A transitional care practice at Northwestern Memorial Hospital helped reduce healthcare costs compared to traditional discharge services, according to a Northwestern Medicine study.
-
Regulator of Cancer ‘Stemness’ Discovered
The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study.
-
Physician Assistant Program Appoints New Director
James Gunn, MMS, PA-C, has been appointed director of the Physician Assistant (PA) Program, effective July 1.
-
Northwestern Scientist Takes Top Honors from Clinical Research Forum
Robert Kushner, MD, received the prestigious Herbert Pardes Clinical Research Excellence Award from the Clinical Research Forum for a study published in NEJM.
-
Salt Substitute is Cost-Effective for Prevention
A salt substitute that contains less sodium was a cost-effective intervention for prevention of stroke and improved quality of life, according to a recent study.
-
Expanding HIV Science
In this feature story, Northwestern scientists share their work at the forefront of HIV research, pioneering new strategies to investigate, treat, and work towards a cure for the disease.
-
Epigenetic ‘Age’ Predicts Cognitive Function
Epigenetic markers of cognitive aging can predict outcomes on cognitive tests later in life, according to a recent Northwestern Medicine study.
-
Improving Interferon Therapy for Blood Cancers
Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular type of blood cancer, according to findings published in Nature Communications. Targeting this pathway in combination with interferon therapy may provide a novel approach to[…]
